Tissue-dependent expression pattern of DC markers
Therapeutic antibodies and anti-drug antibodies (ADA) monitoringTherapeutic antibodies and anti-drug antibodies (ADA) monitoring
A panel of murine monoclonal antibodies against Remicade (DDX5001, DDX5002), Mabthera (DDX5010, DDX5011), Roactemra (DDX5020, DDX5021, DDX5022) and Humira (DDX5030, DDX5031, DDX5032) intended to monitor the level of therapeutic antibodies and anti-drug antibodies (ADA) in patient's sera.
Human CD40L/CD154 transfectantDDX-S2 (murine fibroblaste cell line stably transfected with human CD40L (huCD154)) is intended to stimulate human cells through CD40-CD40L interaction. DDX-S2 significantly supports B cell growth, Ig secretion, in vitro differentiation of monocytes towards dendritic cells, supports plasmacytoid dendritic cells differentiation towards myeloid dendritic cells in the presence of IL-3.
DDX-S2 is supplied under lyophilized formulation, which makes it very stable and easy to handle.
DDX-S2 is stable and functional several weeks (up to 3 months) after resuspension.
rhuGM-CSF (expressed in eukaryote) is now availableDDX-C-rhuGM-CSF is provided as a bioactive protein intended for use in cell culture, differentiation studies ( in vitro generation of dendritic cells) and functional assays (B cell activation).
Human Blood B Booster: the first step toward human monoclonal antibodies
Human IL17A tools
Novel CMV (human cytomegalovirus) antibodyA new monoclonal murine antibody raised against the human cytomegalovirus late antigen gB (DDX9040)
Universal B cell immortalization tools